Spots Global Cancer Trial Database for Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
Official Title: Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
Study ID: NCT02125019
Conditions
Interventions
Study Description
Brief Summary: Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.
Detailed Description: A study assessing the feasibility of evaluating neuropathy symptoms prospectively using testing of gate and balance parameters.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Contact Details
Name: Nicole Williams, MD
Affiliation: Ohio State University Comprehensive Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
